Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1109774

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Staff
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment his department has made of the adequacy of staffing levels in the NHS.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	240946
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>As at December 2018, the National Health Service employed near-record levels of staff, with an increase of almost 72,800 full time equivalent staff since 2010. There are currently over 52,000 nurses in undergraduate training, over 30,000 doctors in undergraduate training, and over 50,000 doctors currently in foundation and specialty postgraduate medical training.</p><p> </p><p>The Government is already increasing nurse training places by 25%, with 5,000 additional nurse training places available every year from September 2018. Additionally, in 2018, up to 5,000 nursing associates commenced training through the apprentice route and the Department has a commitment to train up to a further 7,500 in 2019. The Government also made a commitment to have 5,000 additional doctors in general practice. The Department has started to roll out an extra 1,500 medical school places for domestic students, with the first 630 places taken up in September 2018. By 2020, five new medical schools will have opened to help deliver the expansion.</p><p> </p><p>Furthermore, the NHS Long Term Plan sets out a vital strategic framework to ensure that over the next 10 years the NHS will have the staff it needs, so that nurses and doctors can administer the expert compassionate care they are committed to providing. Baroness Dido Harding, Chair of NHS Improvement, working closely with Sir David Behan, Chair of Health Education England, will lead a number of programmes to develop a detailed workforce implementation plan. Baroness Harding and Sir David will present these initial recommendations to the Department this spring.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 09/04/2019 15:57:08 answering member 1585 label Biography information for Stephen Hammond
	tabling member	308 label Biography information for Mr Jim Cunningham

1109795

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what contingency plans his Department has to mitigate (a) staff and (b) pharmaceutical shortages in the event of the UK leaving the EU without a deal.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	241063
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The Department continues to monitor and analyse overall staffing levels in the health and social care sectors and we have been monitoring leaver and joiner rates of European Union staff on a regular basis since the 2016 referendum. While we do not expect our exit from the EU to lead to a significant number of health staff leaving on or around exit day, we are not complacent and are continually monitoring staffing levels and working with other Government Departments and local areas to put in place mechanisms to respond to any shortages.</p><p> </p><p>We hugely value the contribution of EU staff working in health and social care and the Government has made it clear that we want them to stay. That is why EU staff in health and social care have had early access to the EU Settlement Scheme since December 2018, allowing them to secure their rights to live and work in the United Kingdom. In March 2019, we put in place legislation that ensures the continued recognition of qualifications from EU countries by all professional regulators covering the health and social care sectors. This means EU staff who are currently practising in the UK can continue to do so, and that professionals qualified in the European Economic Area and Switzerland can continue to apply for registration after ‘exit day’, even if we leave without a ‘deal’.</p><p> </p><p>Furthermore, the NHS Long Term Plan sets out a vital strategic framework to ensure that over the next 10 years the National Health Service will have the staff it needs, so that nurses and doctors can administer the expert compassionate care they are committed to providing. Baroness Dido Harding, Chair of NHS Improvement, working closely with Sir David Behan, Chair of Health Education England, will lead a number of programmes to develop a detailed workforce implementation plan. Baroness Harding and Sir David will present these initial recommendations to the Department this spring.</p><p> </p><p>On medicines, the Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the UK in the event of a ‘no deal’ EU exit. This includes the NHS, social care and the independent sector and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).</p><p> </p><p>The Department, together with industry and the NHS, has analysed the supply chains of 12,300 medicines and we are grateful for excellent engagement from all parties, which means our plans are well advanced. As a result of this analysis, the Department has put in place a multi-layered approach to minimise any supply disruption.</p><p> </p><p>We are confident that, if everyone does what they need to do, the supply of medicines and medical products will be uninterrupted in the event of exiting the EU without a deal.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 09/04/2019 16:01:41 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4510 label Biography information for Helen Hayes

1109717

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bipolar Disorder: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with representatives of the NHS on the availability of drugs to treat bi-polar disorders in the event that the UK leaves the EU without a deal.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	241072
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Leaving the European Union with a ‘deal’ remains the Government’s top priority and would give businesses stability and certainty to prepare for our new relationship with the EU after EU exit. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p> </p><p>On 26 March, we wrote to all other organisations in the health and care system to ask them to continue to prepare for leaving the EU without a ‘deal’.</p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care discusses ‘no deal’ contingency plans, including those for the availability of medicines, with a number of stakeholders, including the National Health Service and other Government Departments.</p><p> </p><p>The Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and the Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the United Kingdom in the event of a ‘no deal’ EU exit. This includes the NHS, social care and the independent sector, and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).</p><p> </p><p>We understand that medicines to treat conditions such as epilepsy, bi-polar disorder and neuropathic pain are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the UK from or via the EU/European Economic Area, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 241073 241074 241075 question first answered 09/04/2019 16:00:30 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4523 label Biography information for Catherine West

1109718

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with representatives of the NHS on the availability of drugs to treat epilepsy in the event of that the UK leaves the EU without a deal.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	241073
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Leaving the European Union with a ‘deal’ remains the Government’s top priority and would give businesses stability and certainty to prepare for our new relationship with the EU after EU exit. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p> </p><p>On 26 March, we wrote to all other organisations in the health and care system to ask them to continue to prepare for leaving the EU without a ‘deal’.</p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care discusses ‘no deal’ contingency plans, including those for the availability of medicines, with a number of stakeholders, including the National Health Service and other Government Departments.</p><p> </p><p>The Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and the Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the United Kingdom in the event of a ‘no deal’ EU exit. This includes the NHS, social care and the independent sector, and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).</p><p> </p><p>We understand that medicines to treat conditions such as epilepsy, bi-polar disorder and neuropathic pain are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the UK from or via the EU/European Economic Area, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 241072 241074 241075 question first answered 09/04/2019 16:00:30 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4523 label Biography information for Catherine West

1109719

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Nervous System: Pain
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with representatives of the NHS on the availability of drugs to treat neuropathic pain in the event that the UK leaves the EU without a deal.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	241074
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Leaving the European Union with a ‘deal’ remains the Government’s top priority and would give businesses stability and certainty to prepare for our new relationship with the EU after EU exit. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p> </p><p>On 26 March, we wrote to all other organisations in the health and care system to ask them to continue to prepare for leaving the EU without a ‘deal’.</p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care discusses ‘no deal’ contingency plans, including those for the availability of medicines, with a number of stakeholders, including the National Health Service and other Government Departments.</p><p> </p><p>The Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and the Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the United Kingdom in the event of a ‘no deal’ EU exit. This includes the NHS, social care and the independent sector, and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).</p><p> </p><p>We understand that medicines to treat conditions such as epilepsy, bi-polar disorder and neuropathic pain are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the UK from or via the EU/European Economic Area, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 241072 241073 241075 question first answered 09/04/2019 16:00:30 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4523 label Biography information for Catherine West

1109720

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which drugs has his Department identified as at risk of shortage in the event that the UK leaves the EU without a deal.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	241075
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Leaving the European Union with a ‘deal’ remains the Government’s top priority and would give businesses stability and certainty to prepare for our new relationship with the EU after EU exit. The Department has published guidance to industry and the health and care system to allow them to make informed plans and preparations. This is available on GOV.UK.</p><p> </p><p>On 26 March, we wrote to all other organisations in the health and care system to ask them to continue to prepare for leaving the EU without a ‘deal’.</p><p> </p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care discusses ‘no deal’ contingency plans, including those for the availability of medicines, with a number of stakeholders, including the National Health Service and other Government Departments.</p><p> </p><p>The Department has been working closely with trade bodies, product suppliers, the NHS in England, and the devolved administrations and the Crown Dependencies, to ensure the continuation of the supply of medicines to the whole of the United Kingdom in the event of a ‘no deal’ EU exit. This includes the NHS, social care and the independent sector, and covers licensed medicines (prescription only, pharmacy and general sales list medicines) and unlicensed medicines (specials, investigational medicinal products and UK imports).</p><p> </p><p>We understand that medicines to treat conditions such as epilepsy, bi-polar disorder and neuropathic pain are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the UK from or via the EU/European Economic Area, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 241072 241073 241074 question first answered 09/04/2019 16:00:30 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4523 label Biography information for Catherine West

1109775

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will issue a response to Early Day Motion 1832, on legalisation of medical cannabis.
	tabling member constituency	Glasgow North
	tabling member printed	Patrick Grady
	uin	241057
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The Government is clear that the decision to prescribe a cannabis-based product for medicinal use should only be made where it is clinically appropriate and in the best interest of the patient. This will be subject to local National Health Service governance and funding arrangements for prescribing unlicensed medicines, and patients will not be able to be prescribed such products by their general practitioner – and would require referral to a specialist clinician on the basis of clinical need.</p><p>The evidence base for cannabis-based products for medicinal use is still developing. However, the changes to the law are designed to encourage further research and the National Institute for Health Research has issued two calls for research proposals to rapidly advance knowledge in this area and remains open to research proposals outside of these calls in this priority area.</p><p>Interim clinical guidance, issued by the Royal College of Physicians, British Paediatric Neurology Association and Association of British Neurologists is based on the best available international evidence and reflects clinical guidance that has been published in other jurisdictions. This guidance will be updated and replaced in October 2019 by that commissioned from the National Institute for Health and Care Excellence.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:40:03 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4432 label Biography information for Patrick Grady

1108996

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Travellers and Homelessness
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps (a) his Department plans to take with the NHS to respond to the findings of the Friends Families and Travellers’ report entitled No room at the inn: How easy is it for nomadic Gypsies and Travellers to access primary care and (b) the NHS plans to take to ensure homeless people can access healthcare at any GP practice they choose.
	tabling member constituency	Bermondsey and Old Southwark
	tabling member printed	Neil Coyle
	uin	240011
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Registering with and access to primary medical care services is the same for all patients, whether they are gypsies, travellers, or homeless people. People do not need to provide proof of address to register with a general practice (GP). NHS England is working with a range of community groups to redesign the patient registration leaflet so that people are aware of this when registering. The free NHS 111 service can assist anyone who has faced difficulty finding a GP or accessing other services in their local area.</p><p> </p><p>NHS England is aware of difficulties some individuals have faced when trying to register with a GP and is taking steps to address shortcomings with individual practices, working in partnership with the voluntary sector.</p><p> </p><p>The Voluntary, Community and Social Enterprise Health and Wellbeing Alliance is a partnership arrangement with the aim to facilitate integrated working between the voluntary and statutory sectors, to promote equality and reduce health inequalities. It receives £1.2 million for core work from the Department, with each member receiving funding of up to £60,000. Families and Travellers is a member of the Alliance and have supported the Department on a range of work to date including the Inclusion Health Audit Tool, on maternal health, mental health, end of life care and dementia.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:33:43 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4368 label Biography information for Neil Coyle

1109819

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tomography: Oxfordshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NHS England on the procurement of PET-CT scanning services in Oxfordshire.
	tabling member constituency	Oxford West and Abingdon
	tabling member printed	Layla Moran
	uin	241088
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care meets with NHS England regularly to discuss a variety of topics.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:39:00 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4656 label Biography information for Layla Moran

1109266

	registered interest
	date	02/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity: Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle the rate of cancer caused by obesity.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	239986
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>We published the second chapter of our world-leading childhood obesity plan in June 2018. This builds on the real progress we have made since the publication of chapter one in 2016, particularly in reformulation of the products our children eat and drink most. In chapter two we have set a bold ambition to halve childhood obesity by 2030 and significantly reduce the gap in obesity between children from the most and least deprived areas by 2030.</p><p> </p><p>Many of the measures in both chapters of the plan will have an impact on tackling obesity across all age groups. These include the soft drinks industry levy, sugar reduction and wider calorie reformulation programme, restricting promotions and calorie labelling in restaurants which will improve our eating habits and reduce the amount of sugar we consume.</p><p> </p><p>‘Childhood obesity: a plan for action, chapter 2’ is available at the following link:</p><p> </p><p><a href="http://www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2" target="_blank">www.gov.uk/government/publications/childhood-obesity-a-plan-for-action-chapter-2</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:37:48 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4131 label Biography information for Jim Shannon